Diagnostics of cystic fibrosis and other CFTR-related diseases - analysis of the p.Phe508del mutation of the CFTR gene and over 80 other mutations in exon 11
Analysis of p.Phe508del mutations in the CFTR gene and other mutations in the exon 11

CDT Medicus

Medicover

Synevo
- Test description
Mutation of the CFTR gene Phe508del is the most common mutation in patients with
cystic fibrosis.
It is present in about two-thirds of patients. Detection of pathogenic mutations in
two alleles definitively confirms the diagnosis of cystic fibrosis in a patient
patient.
If during the diagnostic procedure it was possible to identify a mutation
in only one allele or no mutation was identified the result of the
molecular test does not confirm, but also does not exclude the
the diagnosis of cystic fibrosis.
The CFTR WGen is responsible for the production of the CFTR protein, which
is responsible for the proper formation of the membrane channel for ion
chloride, so its mutation results in impaired transport of chloride ions
chloride ions.
Cystic fibrosis is one of the rare diseases of chronic and
systemic with diverse clinical expression. In the classic,
full-blown form of the disease, the most common symptoms are inflammation of the
bronchiolitis and pneumonia, exocrine pancreatic insufficiency and
fertility disorders.
The patient's body produces excessively viscous mucus, which causes
disorders in all organs that have mucus glands
(mainly in the respiratory, digestive and reproductive systems). The glands
sweat glands secrete sweat with an increased concentration of chlorine and sodium.